NB-UVB and PUVA Vitiligo Study
- Conditions
- Vitiligo
- Interventions
- Other: PhototherapyOther: Phototherapy and Photochemotherapy
- Registration Number
- NCT01732965
- Lead Sponsor
- Henry Ford Health System
- Brief Summary
To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Vitiligo affecting more than 15% body surface area.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description NB-UVB phototherapy Phototherapy NB-UVB alone phototherapy and photochemotherapy Phototherapy and Photochemotherapy NB-UVB and PUVA
- Primary Outcome Measures
Name Time Method Determine the quantity of repigmentation 6 months Determination the degree of repigmentation measured by the VASI score (Vitiligo area Scoring Index) after treating with the combination treatments (narrowband ultraviolet B and topical psoralen plus ultraviolet A) and compare it with narrowband ultraviolet B alone.
- Secondary Outcome Measures
Name Time Method Determine the quality of repigmentation. Study initiation, 3 months and 6 months. Determination of the color of repigmentation, pattern of repigmentation, and the cessation of spread of vitiligo after treating with the combination treatments (narrowband ultraviolet B and topical psoralen plus ultraviolet A) and compare it with narrowband ultraviolet B alone.
Trial Locations
- Locations (1)
Henry Ford Dermatology
🇺🇸Detroit, Michigan, United States